HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

Aluna and ModuleMD Provide Remote Patient Monitoring to Respiratory Patients

Aluna | February 07, 2023 | Read time : 02:00 min

ModuleMD and Aluna

Aluna, an award-winning linked care platform and at-home spirometer, and ModuleMD, an ONC-certified EHR, announced a partnership on February 6, 2023, to give more patients and providers access to the latest lung health technology.

Asthma and cystic fibrosis patients can now effortlessly share their daily lung health variations with their doctor, improving results and reducing attacks through earlier and more frequent interventions.

This cooperation will enable easy exchange between physicians, payers, and patients on the Aluna RPM care management platform, with all details incorporated into ModuleMD providers' workflow.

Charvi Shetty, Founder and CEO of Aluna, stated, "Close monitoring of asthma and other lung conditions is correlated with better patient outcomes." "Providers seeking to provide the highest quality care with Aluna can do so efficiently and profitably for their practice, now fully integrated with ModuleMD," she added.

(Source – Cision PR Newswire)

Abhinay Rao, CEO of ModuleMD, remarked, "This partnership represents an important shift in the way clinicians provide patient centered care. For true efficiency, everything needs to be connected to the system of record." He added, "At ModuleMD, our mission is to lead innovation in allergy and pulmonology technology. Through this integration with Aluna, medical practices now have a seamless RPM experience to deliver comprehensive care to patients."

(Source – Cision PR Newswire)

About Aluna

Aluna, a digital spirometry platform certified for use by FDA, gives asthma sufferers and their doctors the ability to monitor their lung function in real-time remotely. The Aluna platform allows practices to offer improved medical care to their patients while simultaneously generating an additional revenue stream through reimbursements for remote patient monitoring (RPM).

Spotlight

Delivering exceptional member engagement experiences isn’t easy. Members expect seamless, convenient access to support and services in whatever channel they prefer. 

Spotlight

Delivering exceptional member engagement experiences isn’t easy. Members expect seamless, convenient access to support and services in whatever channel they prefer. 

Related News

HEALTH TECHNOLOGY

Innovaccer and UpStream Healthcare Expand Partnership to Enhance Senior Care

UpStream | January 27, 2023

On January 26, 2023, Innovaccer, Inc., a data platform for healthcare, announced that it had entered a multiyear partnership with UpStream Healthcare, a value-based primary healthcare provider solution. This partnership entails UpStream more than doubling its population on Innovaccer's cloud-native platform in the coming year, scaling its exceptional value-based care model across the U.S. In April 2022, Innovaccer announced that UpStream Healthcare had selected the Innovaccer Health Cloud, Application Suite and Data Activation Platform to speed up its mission to transform senior healthcare with a full-risk model that improves outcomes, health equity, and care costs. Medicare and Medicare Advantage members on the UpStream platform have a 20-30% lower total cost of care and a 4.5-star quality rating. The company's platform physically embeds a pharmacist-led care team in every primary care physician's office and nurses who visit Medicare-eligible seniors at home. Adding to the point-of-care clinicians, other team members will close any clinical and quality gaps to care for all seniors in full-risk financial agreements. UpStream's clinical partners range from small independent primary care practices to IPAs, with two health systems and two ACO REACH entities supported. The company's data, analytics, and population health technology must scale quickly and cost-effectively to meet growing national demand. The company's platform, powered by Innovaccer Health Cloud, seamlessly integrates with EHRs of new providers and other healthcare IT. As a result, providers can easily access integrated workflows, unified patient records, and point-of-care analytics to deliver high-quality, low-cost care. The expanded partnership follows UpStream's $140 million Series B round, raised to scale its value-based care model across the nation. Since 2018, UpStream has grown to serve over 180,000 Medicare patients and 1,000 primary care physicians in three states. About Innovaccer A California-based health cloud company, Innovaccer Inc., accelerates healthcare innovation. The Innovaccer Health Cloud unifies patient data across systems and care settings, enabling healthcare organizations to develop modern, scalable applications that improve clinical, operational, and financial outcomes. Over 1,600 U.S. care settings use Innovaccer solutions, empowering more than 96,000 providers to transform care delivery and collaborate with life sciences companies and payers. KLAS and Black Book rank Innovaccer #1 in Data and Analytics and Population Health Technology, respectively. About UpStream Headquartered in Greensboro, North Carolina, UpStream is a primary healthcare solution provider that delivers value-based care to older patients and people with chronic conditions. The company offers an all-inclusive, risk-free solution for physicians that provides, finances, and sustains better outcomes by collaborating with healthcare practices and clinics. GAP-QTM (Guaranteed Advanced Payments for Quality) is UpStream's risk-free solution for physicians. GAP-QTM benefits physicians and practices by increasing income, professional satisfaction, and patients by lowering hospitalizations, decreasing copayments, and providing better benefits.

Read More

FUTURE OF HEALTHCARE, DIGITAL HEALTHCARE

Medisafe Launches New SaMD Technology to Enhance Business Solutions

Medisafe | January 05, 2023

Medisafe, a digital therapeutics firm focused on medication engagement, recently introduced SaMD technology. This announcement comes months after receiving ISO 13485:2016 accreditation for medical devices and ISO 27001:2013 certification for pharmaceutical and digital health platforms. These international registrations demonstrate Medisafe's clinical management and patient engagement leadership. With the market for disease management software growing, Medisafe's development shows that the company is committed to following the law, going above and beyond what is expected, and being at the forefront of SaMD development. The achievements made by Medisafe in the past year to better serve patients, doctors, and pharma partners have earned the company a great deal of pride. Medisafe remarked that the most recent announcement of registering as a SaMD is not only a crucial step in the company's development, but it is also essential that it anticipate and address changing customer and industry needs, both regulated and unregulated, as leaders and innovators in digital therapeutics. Medisafe continues to focus on non-regulated business-building solutions that exceed the needs of pharma, HUBs, providers, and patients. Through an interoperable, individualized, and patient-centric approach to digital patient connectivity, Medisafe's end-to-end Care Connector platform enables organizations to effectively engage with patients throughout the medication journey, supporting pharma's vision for a more digitally enhanced future. More than 10 million registrants utilize and rely on Medisafe's platform and digital drug companion to manage their medications, validating the value it brings to patients. Meanwhile, Medisafe will attend the 41st Annual J.P. Morgan Healthcare Conference, which will take place on January 9–12, 2023, in San Francisco, CA, USA. About Medisafe Medisafe® is a premier personalized medication management platform that connects users to their families (and soon, their doctors) for support, encouragement, and expertise to provide customized notifications for visits and refills, prescription updates, personalized health advice, and discounts. It monitors blood pressure and glucose to show the benefits of taking drugs as prescribed. The company improves patient happiness and care by preventing inaccurate or missed dosages.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

KARL STORZ Receives Innovative Technology Designation from Vizient for TIPCAM1 Rubina with ARTip SOLO Robotic Assistance

KARL STORZ | December 21, 2022

KARL STORZ Endoscopy-America, Inc., proudly announces its TIPCAM®1 Rubina® with ARTip® SOLO robotic assistance has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the country. KARL STORZ exhibited TIPCAM1 Rubina with ARTip SOLO at the Vizient Innovative Technology Exchange on Oct. 17 in Dallas, Texas. Each year, healthcare experts serving on Vizient member-led councils review select products and technologies for their potential to enhance clinical care, patient safety, and healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers that these innovations can have a positive impact on patient care and business models. TIPCAM1 Rubina is the only advanced endoscopic solution on the market that gives surgeons access to the most sophisticated visualization technologies of 4K imaging in 2D, 3D, and NIR/ICG, all in one video endoscope using ONE system, the KARL STORZ IMAGE1™ S. The ARTip SOLO robotic camera guidance system, paired with the TIPCAM1 Rubina, allows the operating surgeon to maintain stability and precise control of the field of view. This improves the environment to train surgeons on technical skills, enabling them to operate alone—which can improve efficiency, thereby lowering overall costs. It also provides ideal ergonomics, especially in long procedures. Advanced technologies such as 4K 3D and 4K NIR/ICG provide the ability to visualize crucial details during surgery, often resulting in improved safety and outcomes. 3D has shown to improve task completion time by 64% and reduce errors by 63% especially where suturing is involved. NIR/ICG can reduce complication rates through assessment of blood flow and visualization of critical anatomy. Due to the complexities in surgery, having access to different tools can give a surgeon confidence to properly assess and create a safe surgical plan. The unique combination of the TIPCAM1 Rubina and ARTip SOLO allows hospitals to bridge the gap between robotics and laparoscopy by recreating a robotic experience, incorporating advanced technologies that deliver value without the large capital expense. “KARL STORZ is committed to delivering quality products to allow for optimal surgical flow and advanced patient care. Desirable patient outcomes and improved surgeon ergonomics and autonomy, along with ease of setup enhancing operating room workflow, are just a few of the benefits offered by this innovative endoscopic solution. The advancement in imaging with streamlined robotic assistance allows for use across multiple surgical specialties, in both hospital and ambulatory care settings in rural and urban patient populations, providing equitable access to health care.” Aarathi Cholkeri-Singh, MD, Medical Director at KARL STORZ Endoscopy-America, Inc “Healthcare experts on Vizient member councils evaluated TIPCAM1 Rubina with ARTip SOLO robotic assistance as part of the Innovative Technology Program,” said Kelly Flaharty, Vizient Senior Director of Contract Services. “This designation indicates TIPCAM1 Rubina with ARTip SOLO robotic assistance has one or more qualities that differentiate it from similar products and has potential to make an incremental improvement in healthcare. Congratulations to KARL STORZ.” KARL STORZ Endoscopy-America, Inc., proudly announces its TIPCAM®1 Rubina® with ARTip® SOLO robotic assistance has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the country. KARL STORZ exhibited TIPCAM1 Rubina with ARTip SOLO at the Vizient Innovative Technology Exchange on Oct. 17 in Dallas, Texas. Each year, healthcare experts serving on Vizient member-led councils review select products and technologies for their potential to enhance clinical care, patient safety, and healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers that these innovations can have a positive impact on patient care and business models. TIPCAM1 Rubina is the only advanced endoscopic solution on the market that gives surgeons access to the most sophisticated visualization technologies of 4K imaging in 2D, 3D, and NIR/ICG, all in one video endoscope using ONE system, the KARL STORZ IMAGE1™ S. The ARTip SOLO robotic camera guidance system, paired with the TIPCAM1 Rubina, allows the operating surgeon to maintain stability and precise control of the field of view. This improves the environment to train surgeons on technical skills, enabling them to operate alone—which can improve efficiency, thereby lowering overall costs. It also provides ideal ergonomics, especially in long procedures. Advanced technologies such as 4K 3D and 4K NIR/ICG provide the ability to visualize crucial details during surgery, often resulting in improved safety and outcomes. 3D has shown to improve task completion time by 64% (44 of 69 studies) and reduce errors by 63% (28 of 45 studies), especially where suturing is involved. NIR/ICG can reduce complication rates through assessment of blood flow and visualization of critical anatomy. Due to the complexities in surgery, having access to different tools can give a surgeon confidence to properly assess and create a safe surgical plan. The unique combination of the TIPCAM1 Rubina and ARTip SOLO allows hospitals to bridge the gap between robotics and laparoscopy by recreating a robotic experience, incorporating advanced technologies that deliver value without the large capital expense. “KARL STORZ is committed to delivering quality products to allow for optimal surgical flow and advanced patient care. Desirable patient outcomes and improved surgeon ergonomics and autonomy, along with ease of setup enhancing operating room workflow, are just a few of the benefits offered by this innovative endoscopic solution,” said Aarathi Cholkeri-Singh, MD, Medical Director at KARL STORZ Endoscopy-America, Inc. “The advancement in imaging with streamlined robotic assistance allows for use across multiple surgical specialties, in both hospital and ambulatory care settings in rural and urban patient populations, providing equitable access to health care.” “Healthcare experts on Vizient member councils evaluated TIPCAM1 Rubina with ARTip SOLO robotic assistance as part of the Innovative Technology Program,” said Kelly Flaharty, Vizient Senior Director of Contract Services. “This designation indicates TIPCAM1 Rubina with ARTip SOLO robotic assistance has one or more qualities that differentiate it from similar products and has potential to make an incremental improvement in healthcare. Congratulations to KARL STORZ.” About Vizient Vizient represents a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute healthcare providers and represents approximately $130 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle. About KARL STORZ KARL STORZ Endoscopy-America, Inc. is an innovative leader in endoscopic technology and imaging solutions across virtually all surgical specialties. KARL STORZ provides solutions that facilitate operational and workflow efficiencies across various sites of care, so healthcare providers can deliver optimal patient care in the most cost-effective manner. The group is an affiliate of KARL STORZ SE & Co. KG, an international leader and family-owned company based in Tuttlingen, Germany, that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness.

Read More